loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Govorestat

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Govorestat

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Applied Therapeutics Reports First Quarter 2024 Financial Results
    Applied Therapeutics Reports First Quarter 2024 Financial Results

    09 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/09/2878591/0/en/Applied-Therapeutics-Reports-First-Quarter-2024-Financial-Results.html

    GLOBENEWSWIRE
    09 May 2024
    Share Share
    European regulators close in on Big Tobacco's new tea sticks
    European regulators close in on Big Tobacco's new tea sticks

    28 Mar 2024

    // Emma Rumney REUTERS

    https://www.reuters.com/business/retail-consumer/european-regulators-close-big-tobaccos-new-tea-sticks-2024-03-28/

    Emma Rumney REUTERS
    28 Mar 2024
    Share Share
    Applied Provides FDA Update on PDUFA Target Action Date for Govorestat
    Applied Provides FDA Update on PDUFA Target Action Date for Govorestat

    28 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/03/28/2854501/0/en/Applied-Therapeutics-Provides-FDA-Update-on-PDUFA-Target-Action-Date-for-Govorestat-for-the-Treatment-of-Classic-Galactosemia.html

    GLOBENEWSWIRE
    28 Mar 2024
    Share Share
    Applied Therapeutics Announces Priority Review of NDA for Govorestat
    Applied Therapeutics Announces Priority Review of NDA for Govorestat

    28 Feb 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/02/28/2836879/0/en/Applied-Therapeutics-Announces-FDA-Acceptance-and-Priority-Review-of-New-Drug-Application-for-Govorestat-for-the-Treatment-of-Classic-Galactosemia.html

    GLOBENEWSWIRE
    28 Feb 2024
    Share Share
    Applied Therapeutics Announces Positive Results from Analysis of Govorestat
    Applied Therapeutics Announces Positive Results from Analysis of Govorestat

    15 Feb 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/02/15/2829821/0/en/Applied-Therapeutics-Announces-Positive-Results-from-12-month-Interim-Analysis-of-Govorestat-AT-007-in-the-Ongoing-INSPIRE-Phase-3-Trial-in-Sorbitol-Dehydrogenase-SORD-Deficiency.html

    GLOBENEWSWIRE
    15 Feb 2024
    Share Share
    Applied Therapeutics Announces MAA Validation and NDA Submission of Govorestat
    Applied Therapeutics Announces MAA Validation and NDA Submission of Govorestat

    03 Jan 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/01/03/2803176/0/en/Applied-Therapeutics-Announces-MAA-Validation-and-NDA-Submission-of-Govorestat-AT-007-for-Treatment-of-Classic-Galactosemia.html

    GLOBENEWSWIRE
    03 Jan 2024
    Share Share